Germany Coronary Stents Market Report 2022 to 2030

Germany Coronary Stents Market Analysis

$ 3999

Germany's Coronary Stents Market is expected to witness growth from $414 Mn in 2022 to $522 Mn in 2030 with a CAGR of 2.95% for the forecasted year 2022-30. In Germany, a rising older demographic and an increase in risk factors like obesity and diabetes are projected to contribute to the prevalence of coronary artery disease in Germany. Coronary stent demand as a treatment option is projected to increase as a result. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include B. Braun, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.

ID: IN10DEMD006 CATEGORY: Medical Devices GEOGRAPHY: Germany AUTHOR: Jigyasu Bhandari

Buy Now

Germany Coronary Stents Healthcare Market Executive Analysis

Germany's Coronary Stents Market is expected to witness growth from $414 Mn in 2022 to $522 Mn in 2030 with a CAGR of 2.95% for the forecasted year 2022-30. Germany's current health spending in 2022 is going to account for 13% of GDP. The government provided $72,05 billion in transfers and support in 2021 to pay all of Germany's health-related costs. This was an increase from 2020 of $17.30 billion, or 31.5%. Therefore, 15.7% of the $4581 billion in current health expenditures—an increase of 3% from the previous year—were made up of government payments and subsidies.

In Germany, 1.8 million people have had coronary artery disease diagnosed, while an additional 1 million people have the ailment but are not aware of it. Coronary stents are tiny, mesh-like tubes made of plastic or metal that are used to keep coronary arteries open when they are obstructed or constricted. Coronary artery disease, a disorder in which the arteries that carry blood to the heart narrow or get clogged, is frequently treated in Germany with coronary stents. Stents maintain the artery open and lower the chance of blood clots developing, which helps to enhance blood flow to the heart. Stents can aid in reducing CAD symptoms such as fatigue, shortness of breath, and angina. Stents can assist persons with coronary artery disorders reduce their chance of having a heart attack by enhancing blood flow and lowering their risk of blood clots. Placement of stents is less intrusive and frequently necessitates a shorter hospital stay than other CAD procedures, such as coronary artery bypass surgery.

Germany Coronary Stents Market Analysis

Market Dynamics

Market Growth Drivers

In Germany, a rising older demographic and an increase in risk factors like obesity and diabetes are projected to contribute to the prevalence of coronary artery disease in Germany. Coronary stent demand as a treatment option is projected to increase as a result. The expansion of the coronary stents market in Germany is anticipated to be fueled by the development of new and improved stent designs, such as drug-eluting stents and bioresorbable stents. Compared to more traditional stent designs, these stents offer better results and a lower risk of problems. Stent demand is anticipated to rise as more patients and medical professionals become aware of the advantages of stent placement for the treatment of coronary artery disease. A stent implantation is a less intrusive option to coronary artery bypass surgery, and it is anticipated that this trend towards minimally invasive operations will continue in Germany. This is probably going to increase the demand for stent implantation procedures, which will then increase the demand for coronary stents.

Market Restraints

The German market for coronary stents is highly saturated, with both long-standing manufacturers and recent entrants vying for market dominance. Pricing pressures and decreased manufacturer profitability could result from this. The long-term safety and efficacy of specific stent types, notably drug-eluting stents, have been questioned, despite the fact that coronary stents are often safe and effective. Stent demand may decline as a result, driving up prices for producers and resulting in more scrutiny and control of stent implantation techniques.

Competitive Landscape

Key Players

B. Braun (DE)
Biotronik (DE)
Boston Scientific
Abbott Laboratories
GE Healthcare
Medtronic
Philipps Healthcare

Healthcare Policies and Regulatory Landscape

The Federal Institute for Drugs and Medical Devices (BfArM), which is in charge of supervising the safety, quality, and effectiveness of medical devices, controls the healthcare policies and regulatory environment for coronary stents in Germany. The CE Mark, which certifies that the device complies with the safety and performance standards of the Medical Device Directive (MDD) or the Medical Device Regulation (MDR) of the European Union, is one of the primary regulatory requirements for coronary stents in Germany. The ISO 13485 standard for quality management systems for medical devices must also be followed by manufacturers.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Coronary Stents Market Segmentation

By Type (Revenue, USD Billion):

The three main categories of coronary stents are bare-metal, drug-eluting, and bioabsorbable, depending on their nature. The segment for bioabsorbable stents is anticipated to increase at the fastest rate over the forecast period. The benefits that are encouraging the use of bioabsorbable stents include a decrease in problems including thrombosis and inflammation, the cGermanyity to restore normal vasomotion, and an improvement in aberrant endothelial function. However, in the upcoming years, the expansion of this market segment is anticipated to be constrained by the high cost of bioabsorbable stents.

Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents

By Mode of Delivery (Revenue, USD Billion):

The market is divided into self-expanding and balloon-expandable stents according to delivery method. Because of the high use of these stents, rising research initiatives to advance the technology, and rising regulatory approvals for balloon-expandable stents, the balloon expandable stents segment is anticipated to increase at the greatest CAGR over the projection period.

Balloon-expandable Stents
Self-expanding Stents

By Materials (Revenue, USD Billion):

The coronary stent market is divided into metallic (cobalt chromium, platinum chromium, nickel-titanium, and stainless steel) and other stents according to the material. The market for other stents is anticipated to experience the largest CAGR growth during the projection period. The rapid expansion of this market can be ascribed to the increased use of polymers and copolymers in the production of bioabsorbable stents.

Metallic Stents
Cobalt-Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Other Stents

By End User (Revenue, USD Billion):

The coronary stent market is divided into hospitals, cardiac centres, and ambulatory surgical centres based on the end user. According to predictions, the hospital sector will control the market in 2016. This is primarily caused by hospitals using a lot of coronary stents.

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.